trial · primary record
NT-501 CNTF Implant
Macular Telangiectasia Type 2
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 12 |
| Primary completion | 2028-07-24 |
| Primary endpoint | Rate of Change in Ellipsoid Zone (EZ) Area Loss |
| Registry ID | NCT06397131 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:51.628Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06397131
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.